Our findings are consistent with a previous study25, which showed that women with higher Aβ levels had a faster cognitive decline than men and that women with preclinical AD who were APOE ε4 carriers declined faster than their men counterparts. The gene discussed is APOE; the disease is Alzheimer disease.